<?xml version="1.0" encoding="UTF-8"?>
<p class="p">In a systematic review, Nunes et al. [
 <xref rid="B88-nanomaterials-09-00296" ref-type="bibr" class="xref">88</xref>] focused on the use of solid lipid NPs as oral DESs of phenolic compounds that allow overcoming the pharmacokinetic limitations of these compounds and ameliorate their nutraceutical potential.
</p>
